RxDoctor Payments Data

Andrei Shustov

Hematology & Oncology · Seattle, WANPI 1346247632

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $61,221 of the $63,727 with a category attached, or 96.1%. 9 manufacturers reported payments, led by Acrotech Biopharma Inc. at 32.3% of the total. Reporting peaked in 2021 at $34,778 and has fallen 99.6% since, to $135 in 2024. Among hematology & oncology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,727in general payments, 2019–2025

Across 34 payments — averaging $1874.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acrotech Biopharma Inc.$21K
  • Kyowa Kirin, Inc.$19K
  • Verastem, Inc.$13K
  • Bristol Myers Squibb$8K
  • TG Therapeutics, Inc.$2K
  • Seagen Inc.$206
  • plus $196 from 3 others
$783,945in research payments, 2019–2025

Across 45 payments — averaging $17,421 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$233K
  • E.r. Squibb & Sons, L.L.C.$158K
  • Aurobindo Pharma USA, Inc.$114K
  • Spectrum Pharmaceuticals Inc.$86K
  • Seagen Inc.$77K
  • Otsuka Pharmaceutical Co., Ltd.$63K
  • plus $53K from 2 others

What the payments were for

  • Consulting fees$61,22196%
  • Travel & lodging$1,2212%
  • Food & beverage$1,2852%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,727 in reported general payments places this provider in the 90th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →